GOLDMAN SACHS GROUP INC - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 48 filers reported holding OVID THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$217,943
+0.5%
56,756
-14.2%
0.00%
Q2 2023$216,880
+652.3%
66,122
+491.7%
0.00%
Q1 2023$28,829
+2.3%
11,174
-26.3%
0.00%
Q4 2022$28,188
-57.9%
15,155
-58.0%
0.00%
Q3 2022$67,000
-28.7%
36,074
-17.3%
0.00%
Q2 2022$94,000
-34.3%
43,601
-3.9%
0.00%
Q1 2022$143,000
-9.5%
45,347
-8.2%
0.00%
Q4 2021$158,000
-51.8%
49,389
-49.4%
0.00%
Q3 2021$328,000
-26.1%
97,545
-14.1%
0.00%
Q2 2021$444,000
-85.3%
113,572
-84.9%
0.00%
-100.0%
Q1 2021$3,021,000
+175.6%
751,565
+58.4%
0.00%
Q4 2020$1,096,000
+270.3%
474,545
+821.2%
0.00%
Q3 2020$296,000
-65.0%
51,513
-55.1%
0.00%
Q2 2020$845,000
+108.1%
114,674
-15.8%
0.00%
Q1 2020$406,000
+14.4%
136,251
+59.3%
0.00%
Q4 2019$355,000
+206.0%
85,512
+138.0%
0.00%
Q3 2019$116,000
+33.3%
35,932
-23.1%
0.00%
Q2 2019$87,000
+107.1%
46,729
+98.7%
0.00%
Q1 2019$42,000
+10.5%
23,519
+50.5%
0.00%
Q4 2018$38,000
-75.2%
15,630
-42.0%
0.00%
Q3 2018$153,000
+45.7%
26,959
+81.3%
0.00%
Q1 2018$105,000
-88.6%
14,866
-83.1%
0.00%
Q2 2017$923,00087,9430.00%
Other shareholders
OVID THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
TLS Advisors LLC 1,319,679$4,32918.57%
Madison Avenue Partners, LP 3,307,605$10,848,9432.37%
CHI Advisors LLC 864,822$2,836,6160.86%
Rubric Capital Management LP 5,445,910$17,862,5850.76%
BVF INC/IL 6,851,051$22,471,4470.63%
EcoR1 Capital, LLC 6,117,400$20,065,0720.49%
Artal Group S.A. 2,500,000$8,2000.25%
Tejara Capital Ltd 112,591$369,2980.18%
DCF Advisers, LLC 64,764$212,4260.11%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 801,152$2,627,7790.06%
View complete list of OVID THERAPEUTICS INC shareholders